Loading clinical trials...
Loading clinical trials...
A Prospective, Randomised, Double-Blind, Placebo-Controlled Phase III Study of Modafinil to Improve Fatigue and Quality of Life in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer
Conditions
Interventions
DOCETAXEL(XRP6976) + MODAFINIL
Modafinil
+1 more
Locations
1
Australia
Sanofi-Aventis Administrative Office
Macquarie Park, Australia
Start Date
June 1, 2009
Primary Completion Date
March 1, 2011
Completion Date
March 1, 2011
Last Updated
September 26, 2012
NCT04550494
NCT05245812
NCT05673200
NCT04704661
NCT05372640
NCT07483307
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions